Author/Creator: Bielicki, John K. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Bielicki, John K.

1. [P1–076]: THE ABCA1 AGONIST CS6253 REVERSES APOE4‐DRIVEN ALZHEIMER's DISEASE IN APOE4 TR MICE AND SHOWS CONCOMITANT PLASMA AND BRAIN APOE AND APOJ CHANGES. (1st July 2017)

Authors:: Johansson, Jan O.; Boehm‐Cagan, Anat; Bielicki, John K.; Michaelson, Daniel M.
Journal:: Alzheimer's & dementia
Issue:: Volume 13:Supplement 7S(2017)Part 5
Page Start:: P267
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. [P4–010]: THE ABCA‐1 AGONIST (CS‐6253) REVERSES APOE4 HYPOLIPIDATION IN ALZHEIMER's DISEASE. (1st July 2017)

Authors:: Rawat, Varun; Feng, Qingru; Michaelson, Daniel M.; Chui, Helena C.; Fonteh, Alfred; Johansson, Jan O.; Bielicki, John K.; Harrington, Michael; Yassine, Hussein N.
Journal:: Alzheimer's & dementia
Issue:: Volume 13:Supplement 7S(2017)Part 26
Page Start:: P1257
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. ABCA1 agonist peptides for the treatment of disease. Issue 1 (February 2016)

Authors:: Bielicki, John K.
Journal:: Current opinion in lipidology
Issue:: Volume 27:Issue 1(2016:Feb.)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. O1‐04‐04: The Novel APOE4 Therapeutic CS6253 Penetrates the Blood Brain Barrier, Upregulates the ABCA1 Transporter and Prevents Alzheimer's Disease Pathogenesis. (1st July 2016)

Authors:: Johansson, Jan O.; Boehm-Cagan, Anat; Bielicki, John K.; Michaelson, Daniel M.
Journal:: Alzheimer's & dementia
Issue:: Volume 12:Supplement 7S(2016)Part 3
Page Start:: P181
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. O5‐06‐03: NEW PARADIGMS IN TREATING APOE4‐DRIVEN DEMENTIA DISEASES: PROOF OF CONCEPT AND TRANSLATIONAL FINDINGS FROM STUDIES WITH THE ABCA1 AGONIST THERAPEUTIC CS6253. (1st July 2006)

Authors:: Johansson, Jan O.; Yassine, Hussein N.; Boehm-Cagan, Anat; Zetterberg, Henrik; Winblad, Bengt; Bielicki, John K.; LaDu, Mary Jo; Michaelson, Daniel M.
Journal:: Alzheimer's & dementia
Issue:: Volume 14:Supplement 7(2018)Part 31
Page Start:: P1658
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. P2‐309: Correction of ApoE4 dysfunction and reversal of Alzheimer's disease phenotype and cognition in ApoE4 target replacement mice by cogpepb, an abca1 agonist peptide derived from the lipid binding segment of ApoE. (1st July 2015)

Authors:: Boehm-Cagan, Anat; Johansson, Jan O.; Bielicki, John K.; Michaelson, Daniel M.
Journal:: Alzheimer's & dementia
Issue:: Volume 11(2015)Supplement 7S:Part 13
Page Start:: P611
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. P4‐362: COGPEP™, AN APOE‐DERIVED ABCA1 AGONIST PEPTIDE, REVERSES ALZHEIMER'S DISEASE PHENOTYPE IN HUMAN APOE4 REPLACEMENT MICE. (1st July 2014)

Authors:: Boehm‐Cagan, Anat; Johansson, Jan O.; Bielicki, John K.; Michaelson, Danny
Journal:: Alzheimer's & dementia
Issue:: Volume 10:Supplement 4S(2014)Part 16
Page Start:: P921
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗